Skip to main content
OpenTrials
Completed

NCT Number: NCT00000308

Dextroamphetamine-Cocaine Behavioral Intervention - 5

The purpose of this study is to examine dextroamphetamine-cocaine behavioral intervention in cocaine dependent patients.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cocaine-Related Disorders Chemically-Induced Disorders Mental Disorders Substance-Related Disorders

Age range

18 year–45 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2

Primary location

University of Texas Health Science Center

Houston, Texas, 77225, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Please contact site for information.

Treatment and study plan

Dextroamphetamine

Drug

15 mg of d-amphetamine for first 8 weeks of study and 30 mg for the second 8 weeks

d-amphetamine

Drug

15 mg of d-amphetamine for first 8 weeks of study and 30 mg for the second 8 weeks

Placebo

Drug

placebo

Primary outcomes

  1. Verifiable cocaine abstinence

    Time frame: 16 weeks of study

Sponsors and collaborators

Lead sponsor

National Institute on Drug Abuse (NIDA)

Nih

Collaborators

  • University of Texas

Registry information

Official study title

D-amphetamine-Cocaine Behavioral Intervention

Important dates

Study start
1995
Primary completion
2000
Study completion
2000
First posted
Sep 21, 1999
Registry last updated
Jan 12, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.